Frost & Sullivan, July 2004
to the popularization of this trend.
This research evaluates the current and future prospects of the customer resource management (CRM) market for the U.S. pharmaceuticalindustry in three main segments: SFA
Infiniti Research Limited, Nov 2009, Pages: 21
databases, etc., and CRM can be a very helpful tool in achieving that.
The healthcare industry comprises healthcare service providers, medical device manufacturers, pharmaceutical companies and health
Frost & Sullivan, March 2009, Pages: 25
for the following markets: Global pharmaceuticalCRM market, European insulin delivery devices market, European ophthalmic surgical devices market. The investment themes highlight the scope for undertaking
Key Note Publications Ltd, Sep 2008, Pages: 102
The past 3 years have seen much consolidation in the customer relationship management (CRM) industry, with some of the large CRM players being acquired by even larger software development companies
Frost & Sullivan, June 2002
period.
This Frost & Sullivan analysis offers an up-to-date examination of the global,
interactive, and mobile CRM markets. By highlighting key initiatives and trends,
and providing focused industry
FirstWord Publishing, June 2010, Pages: 45
such as CRM, CSO, discount cards and market segmentation Executive Summary
1. The Global PharmaceuticalIndustry
2. The pharmaceuticalIndustry in Mexico
3. The Mexican pharmaceutical market: Sales values
Eularis, June 2011, Pages: 59
With the ever increasing pressure to ensure maximum return on investment, sales force effectiveness (SFE) is becoming a high priority area in the global pharmaceuticalindustry. Sales force
Business Intelligence [part of Optima Media Group], June 2011, Pages: 326
- from the front line Leading international organizations from a wide range of industries explain their CRM strategies and programmes. They reveal what's working for them, what they've achieved and what
Eularis, June 2011, Pages: 90
. Consideration is given to what they did to measure and improve - and prove - bottom line return.
The Pharmaceutical environment is turbulent and, as a result, what used to work to create industry-wide growth
Datamonitor, March 2010, Pages: 69
This analysis pack looks at the issues of cloud computing adoption within the pharmaceuticals and bio-tech industries of Japan, China, and India. It is based upon a survey conducted in the second
Frost & Sullivan, Jan 2009, Pages: 58
of the pharmaceuticals and life sciences industry. It maps the IT adoption level in pharmaceuticals and life science companies in Australia, with an analysis of the current level of adoption and a projection of future
Frost & Sullivan, Dec 2008, Pages: 46
opportunities in a developing Malaysian IT market for the industry. Application segments that are covered include enterprise resource planning (ERP), customer relationship management (CRM), supply chain
Frost & Sullivan, Dec 2008, Pages: 45
in a maturing Singapore IT market for the industry.
Singapore’s Burgeoning Biomedical Science Sector Fuels Growth in the Pharmaceuticals and Life Sciences IT Market
Bolstered by a vibrant biomedical
Business Insights, Sep 2003, Pages: 122
involvement, significant differences
High involvement, few differences
Low involvement, significant differences
Low involvement, few differences
Pharmaceuticalindustrys position
Chapter 3 New
FirstWord Publishing, Nov 2010, Pages: 43
Unified by geography, culture and language, Latin America nevertheless remains a marketing puzzle for the pharmaceuticalindustry.
Although the Internet is increasing in popularity
GBI Research, June 2011, Pages: 93
technology (IT) in the lifesciences industry will become a trendsetter, helping pharmaceutical companies mitigate current and evolving industry challenges. IT solutions utilized in the value chain
Decision Resources, Inc., Feb 2005, Pages: 89
market was estimated at $16.6 billion. High-growth opportunities within the cardiovascular market include cardiac rhythm management (CRM) and coronary stents--primarily drug-eluting stents (DES).
These two product
Frost & Sullivan, Oct 2003
) is the second application category that is likely to attract investment from pharmaceutical companies as they strive to improve their links with customers. For many, this will be the 'first-time' purchase of CRM
